8-Chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine

Catalog No. :
ACYFPQ028
CAS No. :
117811-20-8
Molecular Formula :
C19H17ClN2
Molecular Weight :
308.81

IUPAC Name:8-Chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine

8-Chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
2mg97%$318.00Login to see priceInquiryInquiry
5mg97%$592.00Login to see priceInquiryInquiry
10mg97%$957.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine
IUPAC Name8-Chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine
Molecular FormulaC19H17ClN2
Molecular Weight308.81
SMILESClC1=CC=C2C(C=CC3=CC=CN=C3/C2=C4CCNCC/4)=C1
InChI KeyDSDQPELJDBELOW-UHFFFAOYSA-N
Synonym8-Chloro-11-(4-piperidinylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine | 13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene | 8-CHLORO-11-(PIPERIDIN-4-YLIDENE)BENZO(5,6)CYCLOHEPTA(1,2-B)PYRIDINE | FT-07
CAS No.117811-20-8
PubChem CID15780509

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYFPQ028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYFPQ028 route product structure diagram
    ACYFPQ028117811-20-8
Inquiry

2. ACYFPQ028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYFPQ028 route product structure diagram
    ACYFPQ028117811-20-8
Inquiry

Comments (0)